Pricing Log in Create free account

Rocket Pharmaceuticals, Inc. (RCKT) vs Vanda Pharmaceuticals Inc. (VNDA)

Rocket Pharmaceuticals, Inc. and Vanda Pharmaceuticals Inc. are both Biotechnology companies. Rocket Pharmaceuticals, Inc. and Vanda Pharmaceuticals Inc. are of similar size ($259.1M and $256.4M). Rocket Pharmaceuticals, Inc. has the higher net margin (0.00% vs −127.4%) and the higher return on invested capital (−114.7% vs −217.6%). Across the 14 metrics below, Rocket Pharmaceuticals, Inc. leads on 11 and Vanda Pharmaceuticals Inc. on 3.

Valuation

Metric RCKT VNDA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.13 9.71
P/B 0.67 1.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.07 n/m 0.64
EV/Sales n/m 0.35 9.21
Earnings yield (7.34%) (114.89%) (33.15%)
Free cash flow yield (69.93%) (63.04%) (25.50%)

Profitability

Metric RCKT VNDA Biotechnology median
Gross margin 0.00% 93.74% 65.16%
Operating margin 0.00% (86.07%) 0.00%
Net margin 0.00% (127.41%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity (4.77%) (77.81%) (56.36%)
Return on assets (4.09%) (53.00%) (48.04%)
Return on invested capital (114.71%) (217.59%) 0.00%

Growth

Metric RCKT VNDA Biotechnology median
Revenue growth (TTM) — 6.02% 6.02%
EPS growth (last fiscal year) 26.37% (1,033.33%) 30.26%
Revenue growth, 5-year CAGR — (2.73%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RCKT VNDA Biotechnology median
Debt to equity 0.05 0.01 0.00
Current ratio 9.24 1.61 4.72
Net debt to EBITDA 0.77 1.84 0.96

Dividend

Metric RCKT VNDA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric RCKT VNDA Biotechnology median
Market cap 259.07m 256.36m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack